Enlivex Therapeutics (ENLV) Stock Price & Financial Analysis
Enlivex Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Enlivex Therapeutics
What is the current stock price for ENLV?
As of the latest trading session, ENLV stock trades at $0.95. The 52-week range is $0.66–$2.10, with a day range of $0.90–$0.99.
What is the P/E ratio for ENLV?
The P/E ratio (Price-to-Earnings) for ENLV is shown in the Key Statistics section. This valuation metric helps compare Enlivex Therapeutics Ltd. to industry peers.
Does ENLV pay dividends?
Enlivex Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENLV?
Based on 1 analyst, the consensus for ENLV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ENLV?
Enlivex Therapeutics's market capitalization is $22.9M, classifying it as a micro-cap company. Enlivex Therapeutics operates in the Healthcare sector within the Biotechnology industry.